← All companies

ABEO

Abeona Therapeutics Inc.

ABEO Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.39

-0.03 -0.47%

Key statistics

from XBRL data in SEC filings

Market cap

$364M

Revenue (TTM)

$5.82M

Net income (TTM)

-$76.2M

EPS (TTM)

$0.95

P/E ratio

6.7

Dividend yield

—

Free cash flow

-$84.3M

Cash

$61.4M

Total assets

$198M

Gross margin

—

52-week range

$4.00 – $7.54

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 12, 2026 8-K Director or officer change Jun 12, 2026 8-K Regulation FD disclosure Jun 10, 2026 8-K Other events Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Director or officer change; Regulation FD disclosure Apr 7, 2026 8-K Amended charter or bylaws Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Results of operations (earnings release) Mar 17, 2026 8-K Other events Mar 9, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jul 18, 2025 8-K Completed an acquisition or disposition; Results of operations (earnings release); Other events Jul 2, 2025 8-K Shareholder vote results May 19, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Entered a material agreement; Other events May 12, 2025 8-K Regulation FD disclosure Apr 29, 2025 8-K Other events Apr 29, 2025 8-K Results of operations (earnings release) Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Director or officer change; Shareholder vote results Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Other events Nov 12, 2024 8-K Other events Oct 29, 2024 8-K Director or officer change Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Amended charter or bylaws Jul 9, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 15, 2024 8-K Entered a material agreement; Other events May 3, 2024 8-K Results of operations (earnings release); Other events May 3, 2024 8-K Director or officer change; Shareholder vote results Apr 24, 2024 8-K Other events Apr 22, 2024